XML 44 R33.htm IDEA: XBRL DOCUMENT v3.19.2
Collaboration Agreements - Transaction Price Related to Consideration Received and Accounts Receivable Allocated to Performance Obligations along with Associated Deferred Revenue (Parenthetical) (Detail) - USD ($)
$ in Thousands
Jun. 30, 2019
Dec. 31, 2018
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]    
Unbilled contract asset $ 180,000 $ 0
Deferred revenue 52,019 0
Net unbilled contract asset 127,981 0
Long-term deferred revenue 102,926 $ 136,109
Europe [Member]    
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]    
Unbilled contract asset 130,000  
Astellas Agreement [Member] | Europe [Member]    
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]    
Unbilled contract asset 130,000  
Deferred revenue 2,019  
Astellas Agreement [Member] | Europe [Member] | Prepaid Expenses and Other Current Assets [Member]    
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]    
Net unbilled contract asset 128,000  
AstraZeneca Agreements [Member]    
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]    
Unbilled contract asset 50,000  
AstraZeneca Agreements [Member] | U.S./RoW [Member]    
Revenue Recognition, Multiple-deliverable Arrangements [Line Items]    
Unbilled contract asset 50,000  
Deferred revenue 152,900  
Net unbilled contract asset 50,000  
Long-term deferred revenue $ 102,900